Higher Levels of Serum Triglycerides Were Associated With Postoperative Deep Vein Thrombosis After Total Hip Arthroplasty in Patients With Nontraumatic Osteonecrosis of the Femoral Head

被引：13

作者：

Xu, Zhihong ^{[1
,2
]}

Dai, Xiaoyu ^{[3
]}

Yao, Yao ^{[1
,2
]}

Shi, Dongquan ^{[1
,2
]}

Chen, Dongyang ^{[1
,2
]}

Dai, Jin ^{[1
,2
]}

Teng, Huajian ^{[2
]}

Jiang, Qing ^{[1
,2
]}

机构：

[1] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China

[2] Nanjing Univ, Nanjing 210008, Jiangsu, Peoples R China

[3] Soochow Univ, Peoples Hosp Changzhou 1, Changzhou, Jiangsu, Peoples R China

来源：

INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS | 2016年 / 15卷 / 01期

关键词：

deep vein thrombosis; lipids; osteonecrosis; femoral head; arthroplasty; VENOUS THROMBOEMBOLISM; RISK; REDUCE;

D O I：

10.1177/1534734615580017

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

This retrospective study aimed to evaluate the association of serum lipids and deep vein thrombosis (DVT) risk following total hip arthroplasty (THA) in patients with nontraumatic osteonecrosis of the femoral head (ONFH). A total of 224 nontraumatic ONFH patients were enrolled. Serum levels of triglycerides (TG), total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol were detected preoperatively. All the patients underwent unilateral lower extremity venography on postoperative days 3 to 5 for DVT screening. In females, patients who were venogram positive for DVT had a higher serum TG level than those who were venogram negative for DVT (P = .029) and a higher TG level was associated with an increased DVT risk (P = .042). Serum TG levels considerably affect DVT risk after THA in female nontraumatic ONFH patients.

引用

页码：41 / 44

页数：4

共 19 条

[1] Cardiovascular risk factors and venous thromboembolism - A meta-analysis [J].

Ageno, Walter ;

Becattini, Cecilia ;

Brighton, Timothy ;

Selby, Rita ;

Kamphuisen, Pieter W. .

CIRCULATION, 2008, 117 (01) :93-102

[2] Does Statin Usage Reduce the Risk of Corticosteroid-Related Osteonecrosis in Renal Transplant Population? [J].

Ajmal, Muhammad ;

Matas, A. J. ;

Kuskowski, Michael ;

Cheng, Edward Y. .

ORTHOPEDIC CLINICS OF NORTH AMERICA, 2009, 40 (02) :235-+

[3]

Chung Lien-Hsiang, 2011, Orthopedics, V34, P15, DOI 10.3928/01477447-20101123-05

[4] Serum lipid levels and the risk of venous thrombosis [J].

Doggen, CJM ;

Smith, NL ;

Lemaitre, RN ;

Heckbert, SR ;

Rosendaal, FR ;

Psaty, BM .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (10) :1970-1975

[5] Prevention of venous thromboembolism [J].

Geerts, William H. ;

Bergqvist, David ;

Pineo, Graham F. ;

Heit, John A. ;

Samama, Charles M. ;

Lassen, Michael R. ;

Colwell, Clifford W. .

CHEST, 2008, 133 (06) :381S-453S

[6]

Glueck C J, 2003, Curr Hematol Rep, V2, P417

[7] Enoxaparin prevents progression of stages I and II osteonecrosis of the hip [J].

Glueck, CJ ;

Freiberg, RA ;

Sieve, L ;

Wang, P .

CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2005, (435) :164-170

[8]

Griffin JH, 2001, THROMB HAEMOSTASIS, V86, P386

[9] Risk Factors for Venous Thromboembolism Results From the Copenhagen City Heart Study [J].

Holst, Anders G. ;

Jensen, Gorm ;

Prescott, Eva .

CIRCULATION, 2010, 121 (17) :1896-1903

[10] The risk of recurrent venous thromboembolism in men and women [J].

Kyrle, PA ;

Minar, E ;

Bialonczyk, C ;

Hirschl, M ;

Weltermann, A ;

Eichinger, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2558-2563

← 1 2 →